A Critical Investigation into the Existence of Circulating Platelet Aggregates

Summary

By a method of counting single platelets in diluted whole blood, platelet aggregates were quantified ex-vivo. Four groups: 20 thrombotic patients, 10 non-thrombotic patients, 10 healthy old controls and 10 healthy young controls were included in the study. Using a 19 gauge needle, with and without tubing, venous blood was taken into buffered EDTA, as a disaggregating agent and buffered EDTA-formalin, as the fixative. The amount of platelet aggregates quantified was affected by the quality of venepuncture or the rate of blood flow through the needle, but was unaffected by the presence of the tubing. There was no statistically significant difference between the four groups, in terms of the platelet aggregates quantified, but scanning electron microscopy revealed the presence of irreversible aggregates, composed of platelet red and white blood cells, in the blood of a greater number of thrombotic patients than non-thrombotic or healthy controls. Platelet aggregates were also quantified in aliquots of platelet rich plasma, and were found to be significantly greater than the corresponding values in whole blood. The difference appeared to be due to increased viscosity of the plasma, induced by the fixative which reduces platelet mobility during centrifugation. It is concluded that the platelet aggregates which disaggregate in bufffered EDTA may represent an artifact of blood collection; the irreversible aggregates are suspected to represent the in vivo circulating aggregates.

Keywords

Circulating platelet aggregates - Platelet count ratio - Irreversible aggregates - White blood

• References

• 1 Prikle B, Carstens P. Pulmonary platelet aggregates associate with sudden death in man. Science 1974; 185: 1062-1064
• 2 Haerem J. Platelet aggregates and mural microthrombi in early stages of acute, fatal coronary disease. Thromb Res 1974; 5: 243-249
• 3 Haerum J. Sudden, unexpected coronary death. The occurrence of platelet aggregates in the epicardial vessels of man. Acta Pathol Microbiol Scand (A) 1978; (Suppl. 265) 7-47
• 4 El-Maraghi N, Genton E. The relevance of platelet and fibrin thromboembolism of the coronary microcirculation, with special reference to sudden cardiac death. Circulation 1980; 62: 936-944
• 5 Wu KK, Hoak JC. A new method for quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 1974; 2: 924-926
• 6 Wu KK, Hoak JC. Increased platelet aggregates in patients with transient ischaemic attacks. Stroke 1975; 6: 521-524
• 7 Prazich JA, Rapaport SI, Samples JR, Engler R. Platelet aggregate ratios - standardisation of a technique and test results in patients with myocardial ischaemia and patients with cerebrovascular disease. Thromb Haemostas 1977; 38: 597-605
• 8 Salem HH, Koutts J, Firkin BG. Circulating platelet aggregates in ischaemic heart disease and their correlation to platelet life span. Thromb Res 1980; 17: 707-711
• 9 Raper CG. Circulating platelet aggregates (Letter). Thromb Haemostas 1978; 39: 537-538
• 10 Bowry SK, Prentice CRM, Courtney JM. A modification of Wu and Hoak method for the determination of platelet aggregates and platelet adhesion. Thromb Haemostas 1985; 53: 381-385
• 11 Kohanna FH, Smith MH, Salzman EW. Do patients with thromboembolic disease have circulating platelet aggregates?. Blood 1984; 64: 205-209
• 12 Saniabadi AR, Lowe G DO, Forbes CD, Prentice CRM, Barbenel JC. Platelet aggregation studies in whole human blood. Thromb Res 1983; 30: 625-632
• 13 Saniabadi AR, Lowe G DO, Belch J JF, Forbes CD, Prentice C RM, Barbenel JC. The novel effects of a new prostacyclin analogue ZK36374 on the aggregation of human platelets in whole blood. Thromb Haemostas 1983; 50: 718-721
• 14 Saniabadi AR, Lowe G DO, Belch J JF, Barbenel JC, Forbes CD. Effect of prostacyclin (Epoprostenol) on the aggregation of human platelets in whole blood in vitro. Haemostasis 1984; 14: 487-494
• 15 Dalton WT, Bollinger P, Brewinko B. A side-by-side evaluation of four platelet counting instruments. Am J Clin Pathol 1980; 74: 119-134
• 16 Jen CJ, McIntyre LV. Characteristics of shear-induced aggregation in whole blood. J Lab Clin Med 1984; 103: 115-124
• 17 Sevitt S. Pathology and pathogenesis of deep vein thrombi. In Superficial and deep venous disorders of the lower limbs Tesi M, Dormandy JA. (Eds.), pp. 45-48 Edizioni Panminerva Medica; Turin: 1984
• 18 Page CP, Archer CB, Paul W, Marley J. Paf-acether: a mediator of inflammation and asthma. Trend Pharmacol Sci 1984; 5: 239-241
• 19 Rhee B, Hall ER, McIntyre LV. Platelet modulation of polymorphonuclear leucocyte shear induced aggregation. Blood 1986; 67: 240-246
• 20 Saniabadi AR, Lowe G DO, Barbenel JC, Forbes CD. Further studies on the role of red blood cells in spontaneous platelet aggregation. Thromb Res 1985; 38: 225-232